For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Takashi Shoda, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshio Takahashi, Corporate Officer in Charge,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.co.jp/

Daiichi Pharmaceutical to Transfer All Daiichi Medical Shares

Tokyo, November 30, 2006 - Daiichi Pharmaceutical Co., Ltd. (President: Kiyoshi Morita; hereafter Daiichi Pharmaceutical), a fully owned subsidiary of DAIICHI SANKYO COMPANY, LIMITED, and QOL Co., Ltd. (President: Masaru Nakamura; hereafter, QOL) have agreed to transfer all shares of Daiichi Medical Co., Ltd. (President: Tomomi Chiba; hereafter, Daiichi Medical), a subsidiary of Daiichi Pharmaceutical, to QOL. The shares are scheduled for transfer on January 5, 2007.

 

Daiichi Medical has been chiefly engaged in the planning and production of scientific and promotional materials as well as the editing and publication of periodicals concerning pharmaceutical products of the Daiichi Pharmaceutical group. In its new role as a fully-owned subsidiary of QOL, the company will focus on production and publication of a broad range of medical related materials.

 

In addition to its key health-insurance pharmacy business, the QOL group intends to strengthen its medical data services and looks forward to Daiichi Medical becoming one of the key players in the QOL group.